Details for New Drug Application (NDA): 019942
✉ Email this page to a colleague
NDA 019942 describes INTRALIPID 30%, which is a drug marketed by Fresenius and is included in one NDA. It is available from two suppliers. Additional details are available on the INTRALIPID 30% profile page.
The generic ingredient in INTRALIPID 30% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
The generic ingredient in INTRALIPID 30% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
Summary for 019942
| Tradename: | INTRALIPID 30% |
| Applicant: | Fresenius |
| Ingredient: | soybean oil |
| Patents: | 0 |
Suppliers and Packaging for NDA: 019942
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| INTRALIPID 30% | soybean oil | INJECTABLE;INJECTION | 019942 | NDA | Baxter Healthcare Corporation | 0338-0520 | 0338-0520-13 | 500 mL in 1 BAG (0338-0520-13) |
| INTRALIPID 30% | soybean oil | INJECTABLE;INJECTION | 019942 | NDA | Fresenius Kabi USA, LLC | 65219-537 | 65219-537-50 | 12 BAG in 1 CASE (65219-537-50) / 500 mL in 1 BAG (65219-537-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 30% | ||||
| Approval Date: | Dec 30, 1993 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
